Tag: Stock pick

The WAM Leaders Ltd (ASX: WLE) fund is paying a dividend yield of 7.2%, fully franked, after its investment portfolio returned 14% for the year.

The 4.8 cent per share final dividend brings the total shareholder return for the year to 24.7%, while the grossed up dividend yield including franking credits comes in at 10.3%.

Fund has been performing well

Lead Portfolio Manager Matthew Haupt said it was a solid year.

He added:

The 2026 financial year was characterised by changing interest rate expectations, geopolitical tensions, global trade disruption and evolving views on the sustainability of artificial intelligence-led growth. These conditions created periods of volatility and meaningful shifts in market leadership, generating opportunities for active investors. The investment team and I adjusted portfolio positioning as conditions evolved, including maintaining exposure to areas of the market where we saw attractive risk-adjusted opportunities, while remaining disciplined on valuation. This approach enabled the investment portfolio to outperform the S&P/ASX 200 Accumulation Index during the year.  

Mr Haupt said the fund would remain focused on high-quality companies trading at attractive valuations.

He added:

Periods of market volatility can create opportunities for active managers, and the investment portfolio is positioned to take advantage of these opportunities as they emerge.

Chair Geoff Wilson said the strong investment performance contributed to a 153.5% increase in operating profit after tax of $161.8 million.

WAM Leaders has increased in value by 12% per year since listing in 2016, while also paying out dividends.

Resources and financials paying off

The fund’s investments include materials at 24.8%, financials at 20.9%, real estate at 13.6%, and consumer discretionary at 10.9%.

In terms of stocks, its largest holdings are in BHP Group Ltd (ASX: BHP), Commonwealth Bank of Australia (ASX: CBA), National Australia Bank Ltd (ASX: NAB), and Wesfarmers Ltd (ASX: WES).

The fund also on August 10 announced a share purchase plan, allowing shareholders to subscribe for up to $30,000 in new shares.

The fund added:

The Board also announced the successful completion of a placement to professional and sophisticated shareholders. Bids exceeded the initial target raise which resulted in the placement bookbuild closing early and allocations being subject to scale back. The final placement size was increased to $225 million in response to the excess demand. The additional capital will enable the investment team to take advantage of investment opportunities for the benefit of all WAM Leaders shareholders.

WAM Leaders shares were changing hands for $1.33. The fund is valued at $2.06 billion.

The post This investment fund is paying a 7.2% dividend yield after solid results appeared first on The Motley Fool Australia.

More reading

• WAM Leaders lifts dividend as portfolio outperforms in FY26
• These ASX 200 shares could generate $10,000 per year in passive income
• How much is needed in superannuation to target a $2,000 monthly passive income?
• 2 ASX blue-chip shares offering big dividend yields
• WAM Leaders wraps $225m placement, lifts FY26 dividend

Motley Fool contributor Cameron England has positions in Wesfarmers. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Wesfarmers. The Motley Fool Australia has recommended BHP Group and Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares are only just inside the green at 9,076.8 points, up 0.04%, on Tuesday.

Among the 11 ASX 200 market sectors today, healthcare is screaming higher, up 7.1%.

This follows earnings releases from sector heavyweights CSL Ltd (ASX: CSL), Cochlear Ltd (ASX: COH), and Pro Medicus Ltd (ASX: PME).

Reliance Worldwide Corp Ltd (ASX: RWC) shares are the fastest risers of the ASX 200 today.

The Reliance share price is up 25% to $4.50 after a takeover offer for $4.75 per share.

Meanwhile on The Bull this week, two experts share their views on three ASX 200 shares.

Let’s take a look.

REA Group Ltd (ASX: REA)

The REA share price is $179.56, up 1.2% today and down 31% over 12 months. 

Tom Fairchild from Lazarus Capital Partners has a buy rating on this ASX 200 communications share. 

He said: 

Revenue from core operations of $1.793 billion in full year 2026 was up 7 per cent on the prior corresponding period.

Net profit after tax from core operations of $650 million was up 15 per cent. Earnings per share of $4.93 was up 15 per cent.

The final fully franked dividend of $1.73 was up 25 per cent.

Investors responded positively after the full year result was released on August 6.

But we believe the company still has ample room to improve its performance from here.

Suncorp Group Ltd (ASX: SUN)

The Suncorp share price is $18.46, down 1.3% today and down 14% over 12 months. 

Andrew Wielandt from DP Wealth Advisory has a hold rating on this ASX 200 financial share.

Wielandt said: 

Suncorp provides insurance products and services. Higher interest rates and bond yields can be a tail wind for the company’s investment portfolio.

Gross written premiums of $15.407 billion were up 2.7 per cent in full year 2026 when compared to the prior corresponding period. Cash earnings of $1.042 billion were down from $1.452 billion in 2025.

An on-market share buy-back of up to $250 million is planned for full year 2027.

All insurance companies are challenged by appropriately pricing risk in a rapidly evolving climate change environment.

It remains our long term concern, so we retain a hold recommendation.

Suncorp shares began trading ex-dividend yesterday.

Northern Star Resources Ltd (ASX: NST)

The Northern Star Resources share price is $22.45, down 3.2% today and up 23% over 12 months. 

Fairchild has a sell rating on this ASX 200 gold share. 

He said: 

The company announced total gold sales of 1.543 million ounces for full year 2026, which was above revised group guidance of 1.5 million ounces.

NST disappointed investors after downgrading production guidance twice in fiscal year 2026 following weaker than expected operational performance.

The shares have fallen from $31.73 on March 2 to trade at $23.28 on August 13.

The company’s final investment decision regarding the Hemi project is targeted for late fiscal year 2027. 

In our view, other gold companies appeal more at this stage of the cycle.

Northern Star will release its full-year FY26 report on Thursday.

The post Buy, hold, sell: REA, Northern Star Resources, Suncorp shares appeared first on The Motley Fool Australia.

More reading

• How to find ASX shares that Warren Buffett might buy
• 3 reasons to buy this rebounding ASX 200 dividend stock today
• Experts name 3 ASX shares to buy this week
• Experts name 3 popular ASX 200 shares to sell today
• Reporting season half-time report: 5 lessons from August so far

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Cochlear. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended CSL, Cochlear, and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Investors who want to earn an easy passive income should consider ASX dividend shares.

There are several options out there. A blue-chip stock could yield anywhere from around 2%, up to riskier high-yield dividend shares which pay out closer to 8% or 10%. Sometimes they pay even more.

If you have the appetite for risk, high-yield shares could provide much higher returns. But only if you know where to look.

Here are two of my picks when it comes to high-yield ASX dividend shares, and they both pay a yield around 8%.

Atlas Arteria Ltd (ASX: ALX)

Atlas Arteria is a global owner, operator, and developer of toll roads, with a portfolio of five toll roads in France, Germany, and the United States. The company was created out of the reorganisation of Macquarie Infrastructure Group in 2010.

The company’s main asset is a roughly 31% stake in Autoroutes Paris-Rhin-Rhone, or APRR. APRR owns concessions to toll more than 2,300 kilometres of motorways in eastern France, most ending in late 2035. The company also wholly owns the Dulles Greenway toll road in the US state of Virginia.

As a toll road operator, Atlas Arteria is a classically defensive infrastructure asset. People will continue to rely heavily on essential infrastructure regardless of what point of the economic cycle we’re in. 

ASX shares like toll roads are also long-duration assets which have visible cash flows across a long period of time. They’re also more reliant on contract renewals and can benefit from toll road increases. They’re not only reliant on traffic growth.

Atlas Arteria typically pays its shareholders two unfranked dividends a year, in April and October, with payments dating back to 2013.

It most recently paid a 20 cent unfranked final dividend to shareholders in April, which equated to a total 40 cent dividend for the year. At the time of writing, that translates to a dividend yield of around 8.1%.

Beach Energy Ltd (ASX: BPT)

Beach Energy produces oil and natural gas from numerous joint venture projects across Australia and New Zealand. Key projects include its onshore Cooper and Eromanga Basin project, which is recognised as Australia’s most prolific oil and gas-producing basin. The project accounts for a substantial slice of the company’s total production. 

Founded in 1961, Beach Energy has expanded through a long series of mergers and acquisitions. It has ownership interests in strategic oil and gas infrastructure and assets, as well as a suite of exploration permits.

Unlike Atlas Arteria, Beach Energy is considered a more cyclical asset, which means the ASX shares can fluctuate depending on commodity prices and what part of the economic cycle we’re in. But the benefit of a cyclical stock is that they tend to outperform during times of recovery.

Beach Energy typically pays shareholders two fully-franked dividends per year, in March and September, with payments dating back to 2005.

It most recently paid an unfranked interim dividend of 1 cent per share in March and announced a 2 cents per share final dividend earlier this month. At the time of writing, that translates to a dividend yield of around 8%.

The post 2 ASX shares with dividend yields above 8% appeared first on The Motley Fool Australia.

More reading

• These ASX 200 shares could generate $10,000 per year in passive income
• 5 things to watch on the ASX 200 on Tuesday
• 5 things to watch on the ASX 200 on Wednesday
• Here are the top 10 ASX 200 shares today
• How much is needed in superannuation for $2,000 in weekly passive income?

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares are up 0.2% to 9,093 points amid a big day of earnings releases on Tuesday.

Let’s take a look at some new expert ratings.

Wildcat Resources Ltd (ASX: WC8)

The Wildcat Resources share price is 40 cents, down 5.4% today and up 101% over 12 months. 

Arthur Garipoli from Dolphin Partners has a buy rating on this ASX 200 lithium share. 

On The Bull this week, Garipoli explained:

This Western Australian explorer is advancing the Tabba Tabba Lithium-Tantalum project, which is a large-scale, hard rock development in an established mining jurisdiction with low sovereign risk and close to Port Hedland infrastructure.

The recent share price fall may represent a good entry opportunity for investors looking for a recovery in lithium markets and in a company with near term catalysts.

WC8 has completed a pre-feasibility study. A large resource base and an upcoming definitive feasibility study de-risks the company.

In our view, WC8 represents a compelling risk-reward scenario.

Centuria Industrial REIT (ASX: CIP)

Centuria Industrial REIT shares are $3.04, down 0.2% today and down 9% over 12 months. 

Bell Potter has a hold rating and $3.35 price target on this ASX real estate investment trust (REIT).

Analyst Andy MacFarlane said:

CIP announced its FY26 result with FFO / share of 18.2c slightly below BPe (-2%) and Visible Alpha consensus (-1%), and at the bottom end of its guidance range.

FY27 guidance provided for FFO / share range of 18.8c – 19.2c (BPe 18.3c; VA consensus 18.7c) and DPS of 17.3c (BPe 16.8c, VA consensus 17.0c).

A solid result for CIP with some plus and minuses, but ultimately the forward earnings outcome to be driven by two leasing campaigns, as it navigates higher CoD which will increase again into FY28 (all else equal) as it explores ways to fund its growth ambitions.

Endeavour Group Ltd (ASX: EDV)

The Endeavour share price is $3.47, down 1.6% today and down 17% over 12 months. 

Garipoli has a sell rating on this ASX 200 consumer staples share. 

He commented on the liquor and hotel operator’s unaudited preliminary results for FY26:

Total group sales of $12.212 billion were up 1.3 per cent on the prior corresponding period. However, total group underlying net profit after tax of $363 million was down from $426 million in full year 2025.

The group expects to recognise after tax significant items, predominately non-cash, of $311 million.

The recent share price recovery since the start of June and August 13 provides an opportunity for investors to cash in some gains.

In our view, better investment opportunities exist elsewhere given recent numbers and high cost of living expenses.

The post Buy, hold, sell: Centuria Industrial REIT, Endeavour, Wildcat Resources shares appeared first on The Motley Fool Australia.

More reading

• How much do I need in my superannuation to earn $50,000 per year in passive income?
• Experts name 3 ASX shares to buy this week
• Buy, hold, sell: Endeavour, JB Hi-Fi, and New Hope shares 
• How much do I need to retire on $100,000 a year at 60?
• 1 ASX dividend stock down 27% I’d buy right now

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Cochlear Ltd (ASX: COH) shares are flying on Tuesday, jumping 7% to $140.90 in afternoon trade and extending their monthly gain to 17%.

Investors have welcomed the hearing-implant leader’s FY26 results, with underlying net profit landing at $322 million — right at the top end of the company’s revised guidance.

That’s a dramatic change in sentiment from April, when Cochlear shares were crushed by around 40% after management slashed its profit outlook. Despite Tuesday’s rebound, the shares remain down 46% year to date and 55% over the past 12 months.

So, what has changed?

Cochlear delivers on revised guidance

Cochlear’s FY26 numbers show a business still facing challenges, but one that’s generating strong cash and continuing to invest heavily in future growth.

Sales revenue increased 2% in constant-currency terms to $2.343 billion. Underlying net profit, however, fell 22% to $322.4 million.

The pressure on profitability was particularly visible in gross margins, which declined from 74% to 71%. Cochlear blamed the deterioration on a less favourable sales mix and production variances.

Still, there were some significant positives.

Operating cash flow surged $130 million to $368 million, while free cash flow also improved substantially. The company continued to invest aggressively in research and development, lifting R&D spending 15% as it accelerated work on its product pipeline.

That investment is already producing results.

Nexa gives investors something to cheer about

Cochlear has launched the Nucleus Nexa System, which it describes as the first smart cochlear implant with upgradeable firmware.

The product has made an impressive start. It quickly accounted for more than 95% of Cochlear’s implant sales across developed markets.

That kind of product momentum could be important as the company attempts to reignite growth in its developed markets.

However, Cochlear isn’t escaping all the pressures facing the business. Gross margins have been squeezed by a greater proportion of lower-priced products being sold in emerging markets. Softer demand in Western Europe and parts of Asia has also weighed on performance.

The company has responded by maintaining tight control over fixed costs and freeing capacity for an additional $25 million of investment in FY27.

What’s next for Cochlear shares?

Management isn’t promising a dramatic recovery overnight. Instead, it expects low single-digit revenue growth in constant-currency terms during FY27.

Underlying net profit is forecast to land between $330 million and $350 million.

Cochlear wants to accelerate adult growth in developed markets by increasing medical engagement and expanding referral pathways. At the same time, it plans to keep investing in R&D and product innovation.

The dividend remains an important part of the shareholder return story. Cochlear declared a final ordinary dividend of $1.30 per share, 85% franked, taking total FY26 dividends to $3.45 per share. That’s down 20% from the previous year.

The company will continue targeting a dividend payout ratio of 70% of underlying net profit.

Cochlear’s balance sheet also gives investors something to watch. Net cash declined, partly because of continued cloud investment and dividend payments. With net cash below management’s preferred level, the on-market share buyback remains inactive.

Gross margins are expected to remain around FY26 levels, while further restructuring costs will factor into the FY27 outlook.

The post Why are Cochlear shares flying 7% higher today? appeared first on The Motley Fool Australia.

More reading

• Cochlear posts FY26 profit at top end of guidance with new product momentum
• Down 50% – Are these the best value ASX 200 shares right now?
• Reporting season half-time report: 5 lessons from August so far
• 5 things to watch on the ASX 200 on Tuesday
• This Warren Buffett quote is particularly relevant for ASX shares at the moment

Motley Fool contributor Marc Van Dinther has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear. The Motley Fool Australia has recommended Cochlear. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Korea Composite Stock Price Index (KOSPI) experienced a devastating peak-to-trough crash of 44% last month.

The KOSPI skyrocketed more than 170% in FY26 due to multiple factors including the artificial intelligence (AI) tailwind.

South Korean chip makers Samsung Electronics and SK Hynix Inc surged a crazy 459% and 807%, respectively, in FY26.

They make up about half of the market’s total market cap, which means KOSPI is a concentrated bet despite being home to 800 stocks.

It’s no surprise that after stock price gains like that, some investors got a bit wary and chose to take their profits and run.

That’s one reason why the KOSPI crashed on 23 June, falling 10% in one day, and sparking a five-week sell-off.

SK Hynix shares lost just over half their value, and Samsung shares dropped 41% before the KOSPI bottomed out on 29 July.

Australian investors who own SK Hynix and Samsung shares directly felt the full force of that fall.

They also felt it via the iShares MSCI South Korea AUD ETF (ASX: IKO) — the Australian market’s top performing ETF of FY26.

IKO ETF delivered an amazing total return of 171% in FY26. The ASX IKO unit price fell 37% during the KOSPI crash.

What’s happened to KOSPI and IKO ETF since the crash?

For the record, IKO ETF doesn’t track the KOSPI.

Instead, the fund seeks to mimic the performance of the MSCI Korea 25/50 Index before fees.

The MSCI Korea 25/50 Index focuses on South Korean large-caps and mid-caps, but in practical terms, it captures 85% of the KOSPI.

SK Hynix and Samsung Electronics make up 46% of the MSCI Korea 25/50 Index market cap.

IKO ETF has been trading for a long time.

Its inception was in the US in May 2000. It was listed on the ASX in November 2017.

IKO was subsequently restructured into an Australian-domiciled ETF in October 2018.

As reflected in IKO ETF’s history in the chart above, the South Korean market has not been a strong performer over the long term.

There are many reasons for this, and it’s summed up by what the professional traders used to call the ‘Korea discount’.

We explain the Korea discount in an earlier story.

Despite its incredible 171% return in FY26, IKO remains a relatively small ASX ETF.

Aussie investors have put about $213 million into the ETF to date, according to ASX data.

That compares to $25.377 billion invested in the market’s largest ETF, Vanguard Australian Shares Index ETF (ASX: VAS).

While small in comparative scale, it’s worth noting the relatively rapid rise in investment in IKO ETF.

ASX investors piled in while watching the KOSPI’s stratospheric rise.

Between January and June 2026 inclusive, IKO’s funds under management rose 40%.

Australians are much more in-tune with overseas markets than they used to be.

Experts agree our home bias toward ASX 200 shares is shifting.

Since bottoming out on 29 July, the KOSPI has rebounded 23%, and IKO has recovered 25%.

SK Hynix shares have lifted 20% and Samsung Electronics stock is 30% higher.

The AI investment megatrend has a long way to go.

As RMIT University finance professor Angel Zhong points out, markets “often move through cycles of exuberance and reassessment”.

Zhong said AI would continue to transform industries:

The AI revolution is creating genuine economic opportunities, but markets often price in expectations long before those benefits are fully realised.

The post How the KOSPI crash impacted ASX investors appeared first on The Motley Fool Australia.

More reading

• Imagine the ASX 200 near-tripling in a year. That’s what the KOSPI did in FY26
• Up 100%, down 40%: Meet the ASX’s craziest ETF
• What were the best and worst-performing ASX ETFs in 2026?
• 3 ASX ETFs that delivered triple-digit returns in FY26
• 6 best international ASX ETFs of FY26

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

ASX shares have rebounded over the past month as inflation and interest-rate concerns have eased.

At the time of writing, the All Ordinaries Index (ASX: XAO) is up around 0.5% for the day. The index is also 3% higher year to date.

The increase is great news for investors, but now many have their eye focused on which ASX shares could climb even higher over the next 12 months.

Here are three stocks which are tipped to outperform the index, and they’re all forecast to jump up to 66% higher.

Catalyst Metals Ltd (ASX: CYL)

Catalyst Metals shares are down around 1.5% and trading at $6.46 a piece, at the time of writing. For the year-to-date, the shares are down around 12%.

It’s been a rocky 12 months for the ASX gold producer’s shares.

The share price spiked to an all-time high in January when the company announced a significant new high-grade discovery at its Plutonic Gold Belt. 

But then the gold stock then shed around 52% of its value to an annual low in early-June. The crash followed headwinds from a weaker gold price, higher mining costs and an investor rotation away from gold shares.

But now it looks like a recovery is in sight and the previous headwinds are turning into tailwinds. Catalyst Metals shares have now rebounded around 37% from the June-low.

Catalyst Metals has a long period of operational consistency and organic growth and looking ahead, the miner expects production to increase towards the latter half of FY26 as well. 

Market Index data shows that brokers agree a strong buy rating on the rate the ASX shares. They tip an average target price of $10.75. That implies a potential 66% upside at the time of writing.

Predictive Discovery Ltd (ASX: PDI)

Predictive Discovery has suffered the same headwinds as Catalyst Metals this year. Higher mining costs, weaker gold prices, and an overall investor rotation away from ASX gold shares into larger, more stable assets, has seen a steep investor sell off. 

The shares fell to an eight-month low of 61 cents a piece in mid-July but have now rebounded around 41%. At the time of writing, the shares are up around 1% for the day and changing hands at 86 cents each.

They’re now 17% higher for the year-to-date and a huge 95% higher than 12 months ago.

And the experts think the gold miner’s shares can keep climbing higher too.

Predictive Discovery’s production numbers are expected to increase in the latter half of the year, with the miner actively developing gold deposits in Guinea’s Siguiri Basin. 

Market Index data shows brokers agree to a strong buy rating on the ASX shares. The maximum target price is $1.35 per share, which implies a potential 57% upside at the time of writing.

Judo Capital Holdings Ltd (ASX: JDO)

Judo was one of the strongest-performing bank shares on the ASX earlier this year. But the stock crashed 46 in late-June after it downgraded its profit guidance for FY26. 

The ASX 200 bank stock revealed that its profit before tax in FY26 is now expected to be between $163 million and $169 million (approximately 30% growth on FY25). This is down from the previous guidance of $180 million to $190 million.

But the bank posted its FY26 results ahead of the market open this morning and it seemed to be much better than the market expected. Judo announced strong gains across the board. NPAT increased 29% to $111.1 million and profit before tax increased 34% to $168.1 million, the top end of Judo’s revised guidance range.

Investors are now rushing back into the stock. At the time of writing, the shares are up an impressive 12% for the day so far, and changing hands at $1.02. It means Judo shares have now recovered around 16% of the losses shed in June, but they’re still 43% lower for the year-to-date and 42% lower than this time last year.

It’s clear that the selloff was way overdone and that the bank is growing stronger than many anticipated. Analysts are very bullish that the stock can keep rebounding higher in coming months.

Market Index data shows the majority of brokers have a strong buy rating on the shares. The $1.49 average target price implies a potential upside of around 51%, at the time of writing. 

The post Brokers tip these 3 ASX shares to climb another 50% to 66% appeared first on The Motley Fool Australia.

More reading

• 2 ASX 200 bank stocks making BIG moves today on results
• Judo Capital reports FY26 earnings and upbeat outlook
• Here are the top 10 ASX 200 shares today
• Here are the top 10 ASX 200 shares today
• 4 ASX 200 gold shares to buy: Experts

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

CSL Ltd (ASX: CSL) shares surged 18% to $158.24 in early afternoon trade on Tuesday That’s a welcome change for shareholders after the ASX healthcare stock lost 42% over the past 12 months.

By comparison, the S&P/ASX 200 Index (ASX: XJO) has gained around 2% over the same period.

Investors appear encouraged by CSL’s latest full-year results and, in particular, management’s outlook following what the company describes as a ‘reset year’.

CSL’s reset year

For the year ended 30 June 2026, CSL reported total revenue of US$15.8 billion, down 1% year-over-year. Underlying NPATA fell 2% to US$3.1 billion.

The headline statutory result was considerably weaker, with CSL reporting a net loss after tax of US$2.6 billion. However, this reflected significant one-off costs and impairments.

CSL spent FY26 undertaking a broad transformation program, including about US$176 million in cost savings, the integration of its Behring and Vifor operations and US$799 million in restructuring costs.

The company also booked US$7.1 billion of pre-tax asset impairments, largely reflecting changes to commercial outlooks, generic competition, regulatory developments and site-utilisation assumptions.

What comes next for CSL shares?

Importantly, management expects FY27 to mark a return towards growth. Revenue is forecast to remain broadly steady, while underlying NPAT is expected to increase by approximately 5%.

CSL Behring is expected to deliver mid-single-digit revenue growth, supported particularly by immunoglobulin demand. CSL Seqirus is targeting low-single-digit growth, although softer US immunisation rates remain a headwind.

Vifor, meanwhile, is expected to decline amid generic competition and regulatory changes.

CSL is also continuing to invest for the longer term. The company announced a new US$1.1 billion share buyback and remains focused on developing new therapies and expanding its US plasma manufacturing network.

It has also entered a strategic partnership with VarmX for a novel blood-coagulation treatment.

What did management say?

Interim CEO and Managing Director Gordon Naylor said:

FY26 has been a year of reset. We have taken decisive action and created a clear path to return to sustainable growth.

Plasma market fundamentals and demand remain robust and momentum is building behind our newer therapies, such as ANDEMBRY® and HEMGENIX.

We have made solid progress on our transformation program and continue to simplify the business. We have also invested in our commercial capabilities and development programs to drive top line growth in the future.

For CSL shareholders, the sharp share price rebound suggests the market is willing to look beyond FY26’s difficult numbers and focus instead on the company’s potential return to sustainable growth.

The post CSL shares surge 18% as ‘reset year’ points to a return to growth appeared first on The Motley Fool Australia.

More reading

• Why is everyone talking about CSL, Pro Medicus and BHP shares on Tuesday?
• How to find ASX shares that Warren Buffett might buy
• How much do I need in my superannuation to earn $50,000 per year in passive income?
• WAM Leaders lifts dividend as portfolio outperforms in FY26
• CSL earnings: FY26 sees reset and path to future growth

Motley Fool contributor Marc Van Dinther has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Already trading near its all-time highs, the All Ordinaries Index (ASX: XAO) is unlikely to return 30% over the coming year, but this ASX All Ords mining stock is tipped to do just that.

That’s according to the team at wealth manager Euroz Hartleys, who recently reiterated their speculative buy rating on BCI Minerals Ltd (ASX: BCI).

In afternoon trade today, BCI Minerals shares are trading for 46 cents apiece. That’s up 27.8% since this time last year. And it gives the ASX All Ords mining stock a market cap of around $1.35 billion.

Looking ahead, Euroz Hartleys is bullish on the potential for BCI’s Mardie Salt Project, located in Western Australia. The project covers some 115 square kilometres on the Pilbara coast. On completion, which is nearing, it will be the third-largest salt project in the world and the largest in Australia, producing 5.35 million tonnes per annum (Mtpa).

MCI is aiming to complete construction of the Mardie Salt Project inside the next half year. First sales are targeted for the end of the first quarter of calendar year 2027 (Q1 2027).

Should I buy the ASX All Ords mining stock today?

BCI announced the results of its June quarter update on 20 July.

In a report released on 11 August, Euroz Hartleys noted, “Development is now 85% complete, with $1.19bn spent to date and the remaining $258m construction cost (+ WC) fully funded by $423m of liquidity.”

The wealth manager added:

Importantly, BCI has commenced salt crystallisation, with 49kt of crystallised salt on hand at 30 Jun ’26, marking a key transition from construction towards operations. BCI expects to be operationally ready for FSOS in Q1 CY27, although first harvest remains weather dependent, with adverse conditions potentially delaying timing by up to 6 months.

Summarising their buy rating on the ASX All Ords mining stock, Euroz Hartleys’ analysts said:

At salt-only steady-state 5.35 mtpa full run-rate (from FY30 on our numbers), BCI is forecast to generate ~$250m EBITDA p.a. with a long asset life (60+yrs) given ‘unlimited’ reserves (seawater), with low sustaining capex providing strong FCF [free cash flow] generation (~$190m p.a.) and the basis for material shareholder returns (assuming 80-100% payout).

Tolling opportunities (i.e. nearby stranded iron ore) from the spare capacity at the 100%-owned 20mtpa Cape Preston West Port offers an additional material revenue stream (>$100m p.a. potential) and SOP (and other waste stream/salt bitterns products) provide very real medium-term upside for staged earnings growth on top of the salt (+$70m EBITDA p.a.).

Euroz Hartleys has a price target of 60 cents per share on the ASX All Ords mining stock.

That represents an upside of more than 30% from the current MCI Minerals share price.

The post Why this $1.4 billion ASX All Ords mining stock is tipped to jump 30% appeared first on The Motley Fool Australia.

More reading

• Brokers name 3 ASX shares to buy with gains of up to 75%

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Owners of BHP Group Ltd (ASX: BHP) shares can celebrate because the ASX mining share has risen 3%, and the BHP dividend has been announced.

The company revealed that revenue grew 15% to US$58.8 billion, profit from operations increased 23% to US$23.9 billion, underlying attributable profit grew 30% to US$13.2 billion, and attributable profit rose 9%.  

Profit generation funds the payment of dividends, so the fact that the company reported significant financial progress was a very helpful sign for the company to fund larger payouts.

Let’s look at how big the dividend payout will be.

BHP FY26 dividend

The ASX mining share wants to provide good passive income payments to shareholders.

The BHP board of directors declared an FY26 final dividend of US 99 cents, representing a 65% increase compared to the final dividend from FY25. That brought the full-year dividend to US$1.72, an increase of 56%.

These payouts mean the business is paying a total distribution of US$8.7 billion to owners of BHP shares, representing 66% of underlying attributable profit. BHP aims to provide investors with a minimum dividend payout ratio of 50% of underlying attributable profit for every reporting period.

Investors can utilise the dividend reinvestment plan (DRP) to receive the dividend as new BHP shares rather than cash.

When will the passive income be paid?

I’ll get to the dividend payment date in a moment, but first investors need to know about the ex-dividend date. Investors wanting to receive the payout need to own shares before the ex-dividend date or else they’ll miss out.

For the FY26 final dividend, BHP disclosed that the ex-dividend date is 3 September 2026, which is just over two weeks. That means investors need to own BHP shares by the end of trading on 2 September 2026 if they want to receive the upcoming payout.

After that date, the ASX mining share will pay its FY26 final dividend per share on 23 September 2026. That means investors only need to wait just over a month until the cash can hit their bank account.

If a shareholder wants to participate in the dividend reinvestment plan, they have until Monday, 7 September 2026 at 5pm to make that election.

What is the BHP dividend yield?

At the current BHP share price and exchange rate, the final dividend of US 99 cents is approximately AU$1.39. That’s a dividend yield of 2.2%, excluding franking credits, and 3.1%, including franking credits.

The full-year dividend of US$1.72 translates into approximately A$2.42. That equates to a dividend yield of 3.8%, excluding franking credits, and 5.4%, including franking credits.

That’s not one of the most exciting dividend yields around, so investors may want to also consider other ASX shares that could be attractive for passive dividend income.

The post Everything you need to know about the BHP dividend appeared first on The Motley Fool Australia.

More reading

• Why is everyone talking about CSL, Pro Medicus and BHP shares on Tuesday?
• How much do I need in my superannuation to earn $50,000 per year in passive income?
• How many BHP shares do I need to buy for $1,000 per month of passive income?
• BHP Group posts record FY26 earnings and flags copper-led future
• A200 vs NDQ: one Betashares ETF is the clear winner

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended BHP Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.